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Summary 
The concentrations of cartilage proteoglycan (aggrecan), stromelysin-1, tissue inhibitor of metalloproteinases-1 
(TIMP-1) and procollagen II C-propeptide in knee joint fluid and the levels of aggrecan, hyaluronan and keratan sulfate 
in serum were measured before and after exercise in 33 healthy athletes. The samples before exercise were obtained 
after 24 h rest from running or soccer and the samples after exercise were obtained 30-60 min after the exercise. Nine 
athletes ran on a treadmill for 60 min, 16 ran on road for 80 rain and 8 played one soccer game (90 rain). A reference 
group of 28 patients with knee pain but not evidence of joint pathology or injury was used for comparison. In joint 
fluid no single marker from the degradative processes in cartilage matrix changed significantly with exercise but all 
showed a rising trend. All markers except stromelysin showed lower concentrations in athletes at rest compared to 
the reference group. In serum from runners before exercise the concentration of keratan sulfate was significantly 
higher than in both the soccer and reference groups and further increased after exercise. The increase in markers after 
exercise may reflect an effect of mechanical loading in combination with a possible high turnover ate of body cartilage 
matrix in these individuals. 
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Introduction 
IN OSTEOARTHRITIS (OA), the disease mechanisms 
active at the tissue and  cell levels are unknown.  
The disease progress is related to degradat ion of 
jo int cart i lage matr ix and 10ss of funct ional  jo int 
carti lage. Studies on experimental  models of sec- 
ondary OA haveshown early changes in the meta- 
bolic, chemical and mechanica l  properties of the 
matr ix before the appearance of radiological 
changes [1]. Injuries to the carti lage, menisci and 
l igaments of the knee often lead to post-traumatic 
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OA [2-7]. These injuries are associated with a 
dramatic increase in the release of cart i lage pro- 
teoglycan (aggrecan) fragments to the jo int  fluid 
[8]. The increased concentrat ion of aggrecan frag- 
ments in the joint fluid reflects an increase in 
matr ix turnover  and could be related to the im 
creased concentrat ions of metal loproteinases in 
jo int  fluid fol lowing t rauma [9-11]. It  has been 
further suggested that  levels of keratan sulfate in 
serum may provide information on the systemic 
changes in metabol ism of cart i lage proteoglycans 
[12-15]. 
Occupational and sports-related joint loading 
may be important risk factors for OA [16-20]. 
Investigations on cartilage matrix metabolism in 
connection with joint loading would thus seem 
warranted.  The purpose of the present study was 
to examine the effects of short-term physical  exer- 
cise in humans on the release of markers  of carti- 
lage matr ix turnover  into knee joint fluid and 
serum. 
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Mater ia l s  and  methods  
A sample of blood and synovial fluid was ob- 
tained from 33 athletes (30 males) before and after 
exercise. There were three types of athletes with 
different training levels: recreational runners, 
mean age 32 years, who ran 5-10 km 2-3 times 
weekly; soccer players, with a mean age of 24 
years, in the Swedish second league and a training 
level of 90 min 4 times weekly; and long distance 
runners and orienteerers, mean age of 31 years, 
with a weekly training dosage of 100-200 km of 
running. Orienteering is a sport in which competi- 
tors in the shortest possible time navigate unfamil- 
iar terrain and locate checkpoints with the aid of 
a map and compass. The athletes were all healthy 
and without knee complaints. The first sample was 
taken at least one day before the planned exercise 
and at least one day after an ordinary training 
event. Three different ypes of physical exercise 
were performed. The recreational runners (N = 9) 
ran on a treadmill for 60 min, the soccer players 
(N = 8) played one soccer game (90 min) and the 
long distance runners (N = 6) and orienteerers 
(N = 10) ran 21kin (75-85min) on road. A new 
sampling of synovial fluid and blood was done 
30-60min after the exercise. The athletes were 
compared to a reference group consisting of 28 
patients (17 males), mean age 25 years, with 
chronic knee pain leading to an arthroscopy but 
with no recent knee injury or joint pathology 
diagnosed by arthroscopy, radiology or blood 
chemistry. Samples from these patients were ob- 
tained at the time of arthroscopy. All procedures 
were approved by the Ethics Review Board of the 
Medical Faculty, University of Lund. 
ASPIRATION OF BLOOD 
The blood samples were aspirated from the 
median antecubital vein, allowed to coagulate, 
centrifuged and the serum stored frozen in aliquots 
at -7O°C until analyzed. 
ASPIRATION OF KNEE JOINT 
Joint fluid samples were aspirated by a lateral 
parapatellar pproach, centrifuged, and aliquots of 
the supernatant frozen and stored in aliquots at 
-70°C within a few hours of collection. 
AGGRECAN FRAGMENTS IN JOINT FLUID 
Aggrecan fragments in joint fluid were 
quantified as sulfated glycosaminoglycan by pre- 
cipitation with Alcian Blue, using chondroitin-6- 
sulfate as standard [21]. Values are expressed as ~g 
sulfated glycosaminoglycan (aggrecan) per ml 
joint fluid. The values obtained with this assay 
represent aggrecan fragments in joint fluid [22] and 
show good correlation with a core protein epitope- 
based assay for aggrecan fragment in joint fluid 
[10, 23]. 
PROCOLLAGEN I I  C -PROPEPTIDE IN JO INT FLUID 
The C-terminal propeptide of collagen type II 
was assayed by an ELISA with the use of rabbit 
antibodies raised against bovine procollagen-II C- 
propeptide immobilized on polystyrene balls [24]. 
Values a re  expressed as ng of procollagen II C- 
prolieptide per ml joint fluid. 
STROMELYSIN AND TISSUE INHIBITOR OF 
METALLOPROTEINASES (TIMP) IN JO INT FLUID 
Stromelysin-1 and TIMP-1 concentrations in 
joint fluid were determined by sandwich ELISA 
using monoclonal and polyclonal antibodies raised 
against he human recombinant proteins, with the 
recombinant human proteins as standards 
[9, 25, 26]. The assay for stromelysin detects the 
proform of the enzyme, the large molecular weight 
active forms or enzyme complexed to TIMP but not 
to alpha-2-macroglobulin. The assay for TIMP-1 as 
used detects free TIMP-1 but not the inhibitor 
complexed with metalloproteinases. Molar ratios 
between stromelysin and TIMP were calculated 
with the assumption that the large majority 
(>90%) of stromelysin in joint fluid in the con- 
ditions examined in this study is present in the 
proform [9, 26]. Values are expressed as nM of 
stromelysin-1 or TIMP-1, respectively. Weight 
ratios between stromelysin and procollagen II C- 
propeptide were also determined in order to ex- 
press the relation between potential degradation 
(stromelysin) and synthesis (procollagen II C- 
propeptide) in cartilage matrix. 
AGGRECAN FRAGMENTS IN SERUM 
Concentrations of aggrecan fragments in serum 
were determined by immunoassay with a poly- 
clonal antibody preparation directed against the 
chondroitin sulfate-bearing domain of aggrecan 
[23]. Values are expressed as ng of intact aggrecan 
per ml serum. 
ASSAY OF KERATAN suLFATE IN SERUM 
Keratan sulfate in serum was measured by an 
ELISA using the 5-D-4 monoclonal antibody [27]. 
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The levels are reported as equivalents  of an inter- 
nat iona l  s tandard  of keratan  sulfate purif ied from 
human costal  cart i lage [12]. Values are expressed 
as ng per ml serum. 
HYALURONAN IN SERUM 
Serum hya luronan was assayed by a commerc ia l  
research  rad ioassay  (Pharmac ia  HA Test 50, Kabi  
Pharmac ia  Diagnost ics,  Uppsala,  Sweden) [28]. 
The assay uti l izes ~2~I-labeled cart i lage prote in 
with affinity for hya luronan and hya luronan-  
subst i tuted Microsepharose.  The labeled prote in 
was par t i t ioned between the unknown amount  of 
hya luronan in serum and a fixed amount  of 
hya luronan bound to the Sepharose gel. The radio- 
act iv i ty  was measured in the gel phase and com~ 
pared with a s tandard curve. The reference range 
of hya luronan in serum is 10-100 #g/1 [29]. 
The stat ist ica l  s igni f icance of dif ferences was 
analyzed by nonparametr i c  tests. The Wi lcoxon 
Matched-Pa i rs  Signed~Rank test  was used to deter- 
mine the dif ferences before and after exercise. The 
Mann-Whi tney  rank-sum test  for two independent  
samples was used to ca lcu late  dif ferences between 
the ath letes and the reference group. A two-tai led 
P -va lue  of < 0.05 was considered signif icant and all 
di f ferences discussed as such are s ignif icant at this 
level or better.  
Resu l ts  
JOINT FLUID 
Volume 
The median vo lume of jo int  fluid asp i rated before 
and after  exercise was 1.0 ml, while the median 
vo lume for the reference group was 0.5 ml (Table I). 
Aggrecan fragments 
No signif icant di f ference in the concent ra t ion  of 
sul fated g lycosaminog lycans  was found in ath letes  
(62pg/ml)  as compared to the reference group 
(69pg/ml)  or in ath letes before vs af ter  exercise 
(Table I). 
Procollagen I I  C-propeptide 
The median concent rat ion  in the ath letes  
(1.3 ng/ml) was lower than  in the reference group 
(2.5 ng/ml) but was unchanged in the ath letes  after  
exercise (Table I). 
Stromelysin-1 
The median concent rat ion  of s t romelys in  was 
h igher  in athletes (6.6 riM) than  in the reference 
Table I 
Markers of cartilage turnover in joint fluid and serum 
Statisticst 
Athletes Athletes 
before after Reference* B/A B/R A/R 
Synovial Fluid 
Volumes 0.9 (0.1-5.5) [17] 1.0 (0.1-10.0 [20] 0.5 (0.01-5.0) [28] NS [9] NS NS 
AGN§ 62 (5-107) [12] 74 (8-213) [17] 69 (32-99) [26] NS [6] NS NS 
pCol-II-C¶ 1.5 (0.4-3.4) [8] 1.2 (0.1-5.7) [15] 2.5 (0.9-8.2) [16] NS [6] S S 
SLNL] 6.6 (0.2-:49.1) [12] 12.0 (0.2-37.5) [20] 4.3 (0.2~42.5) [25] NS [7] S S 
TIMPII 5.0 (0.5-15.6) [12] 6.1 (0.5-13.7) [20] 5.4 (1.9-15.9) [25] NS [8] NS NS 
SLN/TIMP** 1.1 (0.3-7.9) [12] 2.0 (0.1~.1) [20] 0.97 (0.03-3.01) [25] NS [7] S S 
SLN/pC-II-Ctt 6.8 (1.0-30.7) [8] 3.8 (0.5-22.3) [15] 2.2 (0.1-12.2) [16] NS [6] S S 
Serum 
KS$$ 311 (154-500) [32] 329 (154-590) [31] 252 (156-414) [27] S [29] S S 
AGN§§ 275 (110-360) [12] 280 (70-460) [20] 220 (60-400) [26] NS [9] NS NS 
HAl¶¶ 21.8 (0-35.3) [12] 24.7 (11-51.3) [20] 16.8 (11.1-30.9) [27] NS [8] NS S 
The values are expressed as: median (range) IN]. 
*Reference group consisting of 28 subjects with knee pain but normal arthroscopy, radiography and laboratory tests. 
tOnly paired samples were used for the statistical calculation of the difference before and after exercise. B/A = Before vs After 
exercise, B/R = Before exercise vs Reference group, A/R = After exercise vs Reference group. S = P-value < 0.05. NS = P-value > 0.05. 
SVolume of aspirated joint fluid (ml). 
§Aggrecan fragments measured as sulfated glycosaminoglycan (pg/ml). 
¶Procollagen II C-propeptide(ng/ml). 
IIStromelysin-1 and TIMP-1, respectively (n~). 
**Molar ratio of stromelysin to TIMP. 
ttWeight ratio of stromelysin to procollagen II C*propeptide. 
:~:~Keratan sulfate (ng/ml). 
§§Aggrecan fragments measured as aggrecan core protein epitope (ng/ml). 
¶¶Hyaluronan (gg/ml). 
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FIG. l. Concentration ofkeratan sulfate in serum. Left: socce~ players, right: runners before and after exercise. Median 
values for each respective group are given (• - - -A ) .  The shaded zone indicates the 25th and 75th :percentiles of the 
reference group. 
group (4.3 nM) but no difference was seen between 
the athletes before and after exercise (Table I). 
TIMP-1 
No differences in median concentrat ions  were 
found between athletes (5.0 nM) and the reference 
group (5.4 nM) or in athletes before or after exercise 
(Table I). 
Molar ratio stromelysin / TIMP 
The molar ratio of stromelysin to T IMP was 
increased in the athletes (1.1) compared to the 
reference group (0.97) but showed no change after 
exercise (Table I). 
Weight ratio stromelysin /procollagen H 
C-propeptide 
The weight rat io of stromeylsin to procol lagen II
C-propeptide differed in the athletes (6.8) compared 
to the reference group (2.2) but exercise did not 
change the ratio (Table I). 
SERUM 
Aggrecan fragments 
The median concentrat ion  of aggrecan frag- 
ments in serum was higher in athletes (275 ng/ml) 
than in the reference group (220 ng/ml) but exer- 
cise did not inf luence the concentrat ion.  The val- 
ues before or after exercise did not alone differ 
from the reference group (Table I). 
Keratan sulfate 
The median concentrat ion  before exercise was 
311 ng/ml compared to 329 ng/ml after exercise and 
the paired test showed a signif icant difference. The 
concentrat ion  before and after exercise showed a 
h igher  median concentrat ion  than in the reference 
group (252ng/ml) (Table I and Fig. 1). In the 
reference group the median concentrat ion  serum 
keratan  sulfate from males (270 ng/ml) was h igher  
than in females (232 ng/ml). 
Since we found an increased concentrat ion  of 
keratan  sulfate in serum in the athletes compared 
with the reference group, we decided to invest igate 
the effect of the amount  of exercise on serum levels 
of keratan  sulfate. The group of athletes was thus 
divided into soccer players (N = 7 with avai lable 
samples before and after exercise) and runners  
(N = 24). A paired analysis of serum concen- 
t rat ions of keratan sulfate in the soccer players 
before and after exercise showed no dif ference due 
to exercise. In addition, the median concentrat ion  
of keratan  sulfate in the soccer players did not 
differ from the reference group [Fig. l(a)]. How- 
ever, similar analysis of the samples from the 
runners  showed that  at rest they had a h igher 
median concentrat ion  than both the reference 
group and the soccer players (Table II). A further  
paired comparison within the runner  group 
showed an increase due to exercise [Table II, and 
Fig. l(b)]. 
Hyaluronan 
The median concentrat ion before exercise in 
athletes was 21.8#g/1 and after exercise it was 
24.7 #g/1. The value after exercise differs from the 
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reference value of 16.8 pg/1. There was no differ- 
ence between runners and soccer players or be- 
tween values before and after exercise (Tables I 
and II). 
Discuss ion  
A previous study showed a significant increase 
of aggrecan core protein epitopes in paired samples 
after exercise [30]. In the present study we have 
chosen to analyze joint fluid components that are 
suggested to represent both cartilage matrix degra- 
dation (aggrecan fragments, stromelysin and 
TIMP) and synthesis (procollagen II C-propeptide). 
We also compare the findings in joint fluid with 
serum values for aggrecan. In addition, we study 
the serum levels of keratan sulfate, which are 
suggested to mirror systemic body cartilage degra- 
dation [13, 31]. Hyaluronan in serum was shown in 
a previous study to be related to the level of 
physical activity [32]. 
Several different factors may influence the con- 
centrations of cartilage markers in synovial fluid 
and the relevance of the different marker levels are 
not yet clearly understood. An increased release of 
a marker may be caused by either a higher 
turnover rate of the matrix or by an increased 
degradation with a net loss of the marker from the 
matrix to the joint fluid. The marker levels are 
dependent upon both the rate of release from the 
matrix into the joint fluid and the rate of removal 
from the joint compartment [33, 34]. In synovial 
fluid the matrix molecules may be further degraded 
by the synovial cells or removed by bulk flow to the 
lymph circulation. The half-life of aggrecan and 
hyaluronan i  the joint fluid has been estimated to 
be 12-18 h [35]. The degradation: products from the 
matrix are further degraded in the lymph nodes 
before they reach the blood, from which they are 
eliminated via the liver and kidneys [36]. The 
half-life of hyaluronan in circulation is very short 
(a few minutes) [32] and that of keratan sulfate 
some 5-50 min [37]. 
The levels of aggrecan, stromelysin and TIMP 
showed no significant differences before and after 
exercise when analyzed separately, but all three 
markers, which have been suggested to represent 
degradative processes in cartilage matrix, showed 
a rising trend with exercise. This may suggest that, 
taken as a group, the concentrations of these 
markers increase as a result of short-term physical 
exercise. In contrast, procollagen II C-propeptide, 
which is the product of processing of newly syn- 
thesized collagen type II released from the chon- 
drocytes, did not rise in joint fluid concentration as
a result of exercise. Moreover, the levels were 
lower in the athletes when compared with the 
reference group. The calculation of ratios between 
different markers avoids the confounding influence 
of an increased rate of synovial fluid production 
during exercise [33]. The increased ratio between 
stromelysin, representing a potential for carti lage 
degradation, and procollagen II C-propeptide, rep- 
resenting collagen synthesis, among the athletes 
may be consistent with a higher joint carti lage 
degradative activity compared to the reference 
group. 
It is conceivable that the release of markers from 
the matrix is augmented by mechanical loading 
[30, 38]. Such an effect, alone or in combination 
with a higher turnover ate of the matrix in ath- 
letes, can explain the slight increase of aggrecan, 
Table II 
Serum markers in runners and soccer players 
Keratan sulfate* Aggrecan Hyaluronan 
Before exercise 
Runners 351 (154-500) [24] 
Soccer players 266 (217-310) [8] 
After exercise 
Runners 359 (227-590) [24] 
Soccer players 277 (232-307) [7] 
Before vs after 
Runners S [24] 
Before vs after 
Soccer players NS [7] 
Runners vs soccer players 
back exercise S 
Runners vs references 
before exercise S 
Soccer players vs references 
before exercise NS 
250 (110-360) [9] 17.8 (0-35.3) [9] 
280 (70-360) [3] 22.3 (22.1-34.3) [3] 
280 0~0(~460) [15] 26.3 (11.2-51.3) [15] 
265 (240-290) [5] 17.7 (11.0-33.4) [5] 
NS [7] NS [6] 
NS [2] NS [2] 
NS NS 
NS NS 
NS NS 
*See Table I footnotes. 
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stromelysin and TIMP in joint fluid after exercise. 
An increase in trans-synovial transport from the 
joint cavity induced by an increased net filtration 
pressure could be caused by exercise [39] and the 
true release of markers could thus be higher than 
indicated here. 
The aggrecan fragments were measured as chon- 
droitin sulfate by dye precipitation i  the present 
study [21] and the results of this method were 
shown to be in agreement with those found by 
immunoassay [10, 23]. However, it is notable that 
in joint fluid obtained from patients some time 
after a knee injury the levels of aggrecan frag- 
ments measured by dye precipitation are lower 
than if measured by ELISA [10]. The reasons for 
this discrepancy are not clear, but could explain 
the lack of increase in aggrecan fragments after 
exercise in the present study, compared to our 
previous study where the levels of aggrecan frag- 
ments were quantified by the immunoassay method 
[30]. 
The reference group used here included patients 
with chronic knee pain leading to arthroscopy, but 
where careful examination i cluding arthroscopy, 
radiology and blood chemistry failed to reveal any 
joint-related pathology. Nevertheless, this group 
could include some individuals with undiagnosed 
joint disease. It is therefore not surprising that, in 
general, median joint fluid cartilage marker con- 
centrations were somewhat higher in this group 
than in the knee-healthy athletes before exercise. 
For lack of a large group of samples from age- 
matched knee-healthy, nonexercising volunteers, 
we regard the present reference group as an accept- 
able substitute. Joint fluid from the contra-lateral 
knee of unilaterally knee-injured patients is not 
suitable as reference in studies uch as these, since 
the cartilage matrix metabolism has been shown to 
be changed in the uninjured knee as determined by 
joint fluid markers [40]. 
There was no correlation between the concen- 
trations of the markers in joint fluid and serum or 
between the different serum markers, in confor- 
mity with previous findings [31]. Serum concen- 
trations of keratan sulfate vary with age but after 
the age of 15 show little change over a period of 
two or three years [31]. Several reports have shown 
that keratan sulfate concentrations in serum are 
elevated in OA [12, 13, 31], but other studies have 
failed to confirm this [41]. The average serum 
concentration of keratan sulfate in our reference 
group is similar to that of other populations with- 
out OA [12, 13], while the serum concentration i
patients with hip OA [12, 13] and knee OA [31] was 
higher than in the athletes in this study. 
The runners had higher serum concentrations of 
keratan sulfate at rest when compared to both 
soccer players and the reference group. After exer- 
cise the concentration i creased further in these 
individuals, ,a finding which is in contrast o pre- 
vious reports [15, 27, 42]. On the other hand, the 
levels of keratan sulfate in serum at rest and after 
exercise in the soccer players were about the same 
and did not differ from the reference group. In the 
reference group, males had higher serum keratan 
sulfate levels than females, similar to one previous 
report [31], but in contrast o another [12]. Due to 
a disproportion of males between the  reference 
group and the athletes in the present study, a 
gender-matched comparison was performed. How- 
ever, this did not eliminate the difference between 
the runners and the reference group. Several stud- 
ies suggest hat most keratan sulfate-bearing mol- 
ecules in blood represent ~products of the 
degradation of cartilage proteoglycans [14, 15]. 
Only a small proportion of the body cartilage mass 
is, however, located in the joints, with the rest 
being found in the ribs, airways~ intervertebral 
discs, etc. [43]. A marker present in~ioint fluid will 
be representative for the cartilage turnover in a 
single joint while markers present in serum will 
represent an integrated measure of thrnover ac- 
tivity in all joints and possibly all bod~ cartilage 
[44]. Keratan sulfate in serum is perhaps one 
example of a cartilage marker which may serve as 
an indicator of general body cartilage mechanism 
[13] and the results in this study may thus reflect 
a higher cartilage turnover among the runners 
than the other groups. Changes in the matrix 
composition of joint cartilage and intervertebral 
discs in beagle dogs after a long period of vigorous 
running have been shown, possibly reflecting an 
adaptation to enhanced load [45, 46]. The individ- 
uals in the group of runners train very hard and 
could thus exercise their tracheobronchial-, costal- 
and joint cartilage, as well as intervertebral discs. 
The difference in keratan sulfate levels in serum 
between the soccer players and runners could be 
an effect of different physical activity in the two 
sports. 
No significant effect of exercise was noted on 
serum levels of hyaluronan or aggrecan fragments. 
The increased values of hyaluronan among the 
athletes compared to the reference group, consist- 
ent with previous findings on the relation of 
hyaluronan to activity level [47], may be due to the 
athletes as a group being more physically active. 
Since the post-exercise samplings were performed 
30~0 min after the exercise, the short half-life of 
hyaluronan in serum could explain the unchanged 
values after exercise, which is in contrast o the 
previously cited study [47]. 
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There  is no c lear  ev idence that  the moderate  
changes  in cart i lage markers  in jo int  fluid and 
serum shown herb to resu l t  f rom physical  exercise 
ref lect a harmfu l  effect on jo int  cart i lage.  The most  
re l iable exp lanat ion  is probab ly  that  the h igher  
car t i lage turnover  rate  is responsib le for the sl ight 
increases in marker  concent ra t ions  among the 
athletes.  Publ ished reports  on cart i lage markers  in 
jo int  fluid and serum f requent ly  lack contro l  
groups; the resul ts  presented here could thus serve 
as a useful  re ference for cont inued work  on these 
markers .  
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